Neurodegenerative diseases (ND) such as AD and Parkinson’s disease (PD) were enriched in the KEGG according to network pharmacology and proteomics, so we inferred that ALL may act on the CX3CL-CX3CR1 axis and suppress neuroinflammation to achieve neuroprotection. The gene discussed is CX3CR1; the disease is Alzheimer disease.